IL6 and silicosis: The authors concluded that the combination of tetrandrine and acetylcysteinehas an improved therapeutic effect on silicosis and can mitigate the severity of theinflammatory reaction in patients with this disease, and that levels of IL-6 andTNF-α in peripheral blood may be valuable to guide clinical treatment ofsilicosis.31